Traders purchased shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading on Monday. $94.64 million flowed into the stock on the tick-up and $63.59 million flowed out of the stock on the tick-down, for a money net flow of $31.05 million into the stock. Of all companies tracked, UnitedHealth Group had the 17th highest net in-flow for the day. UnitedHealth Group traded down ($1.96) for the day and closed at $141.73

UNH has been the topic of a number of recent analyst reports. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Morgan Stanley reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Jefferies Group reaffirmed a “buy” rating and issued a $153.00 target price on shares of UnitedHealth Group in a research report on Tuesday, May 17th. Finally, FBR & Co reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, April 20th. One investment analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $153.44.

The firm’s 50 day moving average price is $139.97 and its 200-day moving average price is $128.13. The firm has a market cap of $137.05 billion and a P/E ratio of 22.18.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. Equities analysts forecast that UnitedHealth Group Inc. will post $7.90 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Friday, June 17th were given a $0.625 dividend. The ex-dividend date was Wednesday, June 15th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.76%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.50.

In other news, Director Gail R. Wilensky sold 5,500 shares of the business’s stock in a transaction that occurred on Friday, June 10th. The shares were sold at an average price of $139.80, for a total value of $768,900.00. Following the transaction, the director now owns 59,019 shares in the company, valued at approximately $8,250,856.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, June 16th. The stock was sold at an average price of $138.58, for a total transaction of $692,900.00. Following the completion of the transaction, the director now owns 72,229 shares in the company, valued at approximately $10,009,494.82. The disclosure for this sale can be found here.

Other hedge funds and institutional investors recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in UnitedHealth Group by 1.8% in the fourth quarter. Vanguard Group Inc. now owns 54,496,944 shares of the healthcare conglomerate’s stock worth $6,411,021,000 after buying an additional 981,470 shares during the last quarter. Wells Fargo & Company MN increased its position in UnitedHealth Group by 12.0% in the fourth quarter. Wells Fargo & Company MN now owns 7,953,096 shares of the healthcare conglomerate’s stock worth $935,602,000 after buying an additional 854,667 shares during the last quarter. Jennison Associates LLC increased its position in UnitedHealth Group by 96.4% in the fourth quarter. Jennison Associates LLC now owns 785,534 shares of the healthcare conglomerate’s stock worth $92,410,000 after buying an additional 385,632 shares during the last quarter. Marshall Wace LLP increased its position in UnitedHealth Group by 224.0% in the fourth quarter. Marshall Wace LLP now owns 486,564 shares of the healthcare conglomerate’s stock worth $57,240,000 after buying an additional 336,405 shares during the last quarter. Finally, CI Investments Inc. increased its position in UnitedHealth Group by 55.4% in the fourth quarter. CI Investments Inc. now owns 727,400 shares of the healthcare conglomerate’s stock worth $85,571,000 after buying an additional 259,200 shares during the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.